A Multicenter, Randomized, Double-blind, Parallel-group Fixed-dose Study of the Effect on Weight of Bifeprunox Versus Risperidone in the Treatment of Outpatients With Schizophrenia.

Trial Profile

A Multicenter, Randomized, Double-blind, Parallel-group Fixed-dose Study of the Effect on Weight of Bifeprunox Versus Risperidone in the Treatment of Outpatients With Schizophrenia.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 08 Feb 2013

At a glance

  • Drugs Bifeprunox (Primary) ; Risperidone
  • Indications Schizophrenia
  • Focus Adverse reactions; Registrational
  • Sponsors Wyeth
  • Most Recent Events

    • 01 Mar 2008 Status changed from suspended to discontinued according to Clinicaltrials.gov record.
    • 09 Jan 2008 Status changed from recruiting to suspended.
    • 03 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top